nodes	percent_of_prediction	percent_of_DWPC	metapath
Enoxaparin—SERPINC1—liver—sarcoma	0.0392	0.196	CbGeAlD
Enoxaparin—SERPINC1—Complement and Coagulation Cascades—CR2—sarcoma	0.0376	0.21	CbGpPWpGaD
Enoxaparin—F10—mammary gland—sarcoma	0.0271	0.136	CbGeAlD
Enoxaparin—SERPINC1—Glypican 1 network—FLT1—sarcoma	0.0244	0.136	CbGpPWpGaD
Enoxaparin—F10—Complement and Coagulation Cascades—CR2—sarcoma	0.0212	0.119	CbGpPWpGaD
Enoxaparin—MPO—endothelium—sarcoma	0.0183	0.092	CbGeAlD
Enoxaparin—Haemorrhage intracranial—Mitoxantrone—sarcoma	0.0166	0.0267	CcSEcCtD
Enoxaparin—F10—hematopoietic system—sarcoma	0.0165	0.0827	CbGeAlD
Enoxaparin—Skin necrosis—Etoposide—sarcoma	0.0162	0.0261	CcSEcCtD
Enoxaparin—F10—cardiac atrium—sarcoma	0.0125	0.0628	CbGeAlD
Enoxaparin—Local reaction—Mitoxantrone—sarcoma	0.0123	0.0198	CcSEcCtD
Enoxaparin—Injection site haemorrhage—Epirubicin—sarcoma	0.0118	0.019	CcSEcCtD
Enoxaparin—F10—tendon—sarcoma	0.0109	0.0547	CbGeAlD
Enoxaparin—Injection site haemorrhage—Doxorubicin—sarcoma	0.0109	0.0176	CcSEcCtD
Enoxaparin—Paralysis—Vincristine—sarcoma	0.0101	0.0162	CcSEcCtD
Enoxaparin—Injection site pain—Thiotepa—sarcoma	0.00966	0.0155	CcSEcCtD
Enoxaparin—Skin necrosis—Epirubicin—sarcoma	0.00909	0.0146	CcSEcCtD
Enoxaparin—F10—testis—sarcoma	0.00904	0.0453	CbGeAlD
Enoxaparin—MPO—hematopoietic system—sarcoma	0.00901	0.0452	CbGeAlD
Enoxaparin—MPO—connective tissue—sarcoma	0.00868	0.0435	CbGeAlD
Enoxaparin—MPO—Vitamin B12 Metabolism—HBA1—sarcoma	0.0086	0.048	CbGpPWpGaD
Enoxaparin—F10—liver—sarcoma	0.00855	0.0428	CbGeAlD
Enoxaparin—Skin necrosis—Doxorubicin—sarcoma	0.00841	0.0135	CcSEcCtD
Enoxaparin—SERPINC1—Glypican 1 network—SRC—sarcoma	0.00795	0.0444	CbGpPWpGaD
Enoxaparin—MPO—skin of body—sarcoma	0.00783	0.0393	CbGeAlD
Enoxaparin—SERPINC1—Glypican 1 network—VEGFA—sarcoma	0.00775	0.0433	CbGpPWpGaD
Enoxaparin—Skin exfoliation—Thiotepa—sarcoma	0.00753	0.0121	CcSEcCtD
Enoxaparin—Pulmonary oedema—Thiotepa—sarcoma	0.00702	0.0113	CcSEcCtD
Enoxaparin—MPO—Folate Metabolism—HBA1—sarcoma	0.007	0.0391	CbGpPWpGaD
Enoxaparin—MPO—C-MYB transcription factor network—MYOD1—sarcoma	0.00696	0.0389	CbGpPWpGaD
Enoxaparin—MPO—C-MYB transcription factor network—CD34—sarcoma	0.00696	0.0389	CbGpPWpGaD
Enoxaparin—Hyperkalaemia—Mitoxantrone—sarcoma	0.00669	0.0108	CcSEcCtD
Enoxaparin—F10—lymph node—sarcoma	0.00655	0.0328	CbGeAlD
Enoxaparin—MPO—lymphoid tissue—sarcoma	0.00634	0.0318	CbGeAlD
Enoxaparin—Ecchymosis—Mitoxantrone—sarcoma	0.00616	0.00991	CcSEcCtD
Enoxaparin—Cardiac failure—Thiotepa—sarcoma	0.00587	0.00944	CcSEcCtD
Enoxaparin—Inflammation—Etoposide—sarcoma	0.00584	0.0094	CcSEcCtD
Enoxaparin—MPO—bone marrow—sarcoma	0.00578	0.029	CbGeAlD
Enoxaparin—Local reaction—Epirubicin—sarcoma	0.00574	0.00923	CcSEcCtD
Enoxaparin—Vesiculobullous rash—Epirubicin—sarcoma	0.00567	0.00912	CcSEcCtD
Enoxaparin—MPO—Selenium Micronutrient Network—HBA1—sarcoma	0.00556	0.0311	CbGpPWpGaD
Enoxaparin—Skin exfoliation—Etoposide—sarcoma	0.00541	0.0087	CcSEcCtD
Enoxaparin—Local reaction—Doxorubicin—sarcoma	0.00531	0.00854	CcSEcCtD
Enoxaparin—Vesiculobullous rash—Doxorubicin—sarcoma	0.00524	0.00844	CcSEcCtD
Enoxaparin—Aspartate aminotransferase increased—Thiotepa—sarcoma	0.00516	0.0083	CcSEcCtD
Enoxaparin—Aspartate aminotransferase increased—Dactinomycin—sarcoma	0.00512	0.00823	CcSEcCtD
Enoxaparin—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.00511	0.00822	CcSEcCtD
Enoxaparin—Thrombocytosis—Epirubicin—sarcoma	0.00511	0.00822	CcSEcCtD
Enoxaparin—Cardiac failure—Mitoxantrone—sarcoma	0.00507	0.00815	CcSEcCtD
Enoxaparin—Alanine aminotransferase increased—Thiotepa—sarcoma	0.00505	0.00813	CcSEcCtD
Enoxaparin—MPO—testis—sarcoma	0.00494	0.0248	CbGeAlD
Enoxaparin—Thrombocytosis—Doxorubicin—sarcoma	0.00473	0.0076	CcSEcCtD
Enoxaparin—MPO—liver—sarcoma	0.00467	0.0234	CbGeAlD
Enoxaparin—Aspartate aminotransferase increased—Vincristine—sarcoma	0.00457	0.00736	CcSEcCtD
Enoxaparin—Paralysis—Epirubicin—sarcoma	0.00457	0.00736	CcSEcCtD
Enoxaparin—Thrombosis—Epirubicin—sarcoma	0.00449	0.00722	CcSEcCtD
Enoxaparin—Aspartate aminotransferase increased—Mitoxantrone—sarcoma	0.00445	0.00716	CcSEcCtD
Enoxaparin—Pneumonia—Thiotepa—sarcoma	0.00444	0.00714	CcSEcCtD
Enoxaparin—Hyperlipidaemia—Epirubicin—sarcoma	0.00441	0.00709	CcSEcCtD
Enoxaparin—Pneumonia—Dactinomycin—sarcoma	0.00441	0.00709	CcSEcCtD
Enoxaparin—Alanine aminotransferase increased—Mitoxantrone—sarcoma	0.00436	0.00702	CcSEcCtD
Enoxaparin—Dermatitis atopic—Epirubicin—sarcoma	0.00429	0.0069	CcSEcCtD
Enoxaparin—Anaphylactoid reaction—Etoposide—sarcoma	0.00425	0.00684	CcSEcCtD
Enoxaparin—Paralysis—Doxorubicin—sarcoma	0.00423	0.00681	CcSEcCtD
Enoxaparin—Cardiac failure—Etoposide—sarcoma	0.00421	0.00678	CcSEcCtD
Enoxaparin—Haematuria—Thiotepa—sarcoma	0.00421	0.00677	CcSEcCtD
Enoxaparin—Thrombosis—Doxorubicin—sarcoma	0.00415	0.00668	CcSEcCtD
Enoxaparin—Hyperlipidaemia—Doxorubicin—sarcoma	0.00408	0.00656	CcSEcCtD
Enoxaparin—Rash pustular—Epirubicin—sarcoma	0.00398	0.00641	CcSEcCtD
Enoxaparin—Haemoglobin—Thiotepa—sarcoma	0.00398	0.00641	CcSEcCtD
Enoxaparin—Dermatitis atopic—Doxorubicin—sarcoma	0.00397	0.00639	CcSEcCtD
Enoxaparin—Haemorrhage—Thiotepa—sarcoma	0.00396	0.00637	CcSEcCtD
Enoxaparin—Pneumonia—Vincristine—sarcoma	0.00394	0.00633	CcSEcCtD
Enoxaparin—Injection site pain—Epirubicin—sarcoma	0.00389	0.00626	CcSEcCtD
Enoxaparin—SERPINC1—Hemostasis—TEK—sarcoma	0.00387	0.0216	CbGpPWpGaD
Enoxaparin—Myocardial infarction—Vincristine—sarcoma	0.00384	0.00617	CcSEcCtD
Enoxaparin—Pneumonia—Mitoxantrone—sarcoma	0.00383	0.00617	CcSEcCtD
Enoxaparin—Myocardial infarction—Mitoxantrone—sarcoma	0.00374	0.00601	CcSEcCtD
Enoxaparin—Rash pustular—Doxorubicin—sarcoma	0.00368	0.00593	CcSEcCtD
Enoxaparin—Haematuria—Mitoxantrone—sarcoma	0.00363	0.00585	CcSEcCtD
Enoxaparin—Alanine aminotransferase increased—Etoposide—sarcoma	0.00363	0.00584	CcSEcCtD
Enoxaparin—MPO—IL23-mediated signaling events—IL2—sarcoma	0.00361	0.0202	CbGpPWpGaD
Enoxaparin—Injection site pain—Doxorubicin—sarcoma	0.0036	0.00579	CcSEcCtD
Enoxaparin—MPO—lymph node—sarcoma	0.00358	0.0179	CbGeAlD
Enoxaparin—SERPINC1—Hemostasis—ANGPT2—sarcoma	0.00354	0.0197	CbGpPWpGaD
Enoxaparin—Alopecia—Thiotepa—sarcoma	0.0035	0.00563	CcSEcCtD
Enoxaparin—Alopecia—Dactinomycin—sarcoma	0.00347	0.00559	CcSEcCtD
Enoxaparin—Erythema—Thiotepa—sarcoma	0.00345	0.00555	CcSEcCtD
Enoxaparin—Haemoglobin—Mitoxantrone—sarcoma	0.00344	0.00553	CcSEcCtD
Enoxaparin—Erythema—Dactinomycin—sarcoma	0.00342	0.00551	CcSEcCtD
Enoxaparin—Haemorrhage—Mitoxantrone—sarcoma	0.00342	0.0055	CcSEcCtD
Enoxaparin—Inflammation—Epirubicin—sarcoma	0.00327	0.00527	CcSEcCtD
Enoxaparin—Pneumonia—Etoposide—sarcoma	0.00319	0.00513	CcSEcCtD
Enoxaparin—Anaemia—Thiotepa—sarcoma	0.00319	0.00513	CcSEcCtD
Enoxaparin—Hepatocellular injury—Epirubicin—sarcoma	0.00318	0.00511	CcSEcCtD
Enoxaparin—Anaemia—Dactinomycin—sarcoma	0.00316	0.00509	CcSEcCtD
Enoxaparin—Hyperkalaemia—Epirubicin—sarcoma	0.00312	0.00502	CcSEcCtD
Enoxaparin—Myocardial infarction—Etoposide—sarcoma	0.00311	0.005	CcSEcCtD
Enoxaparin—Alopecia—Vincristine—sarcoma	0.0031	0.00499	CcSEcCtD
Enoxaparin—Malaise—Dactinomycin—sarcoma	0.00309	0.00497	CcSEcCtD
Enoxaparin—Skin exfoliation—Epirubicin—sarcoma	0.00303	0.00488	CcSEcCtD
Enoxaparin—Inflammation—Doxorubicin—sarcoma	0.00303	0.00488	CcSEcCtD
Enoxaparin—Alopecia—Mitoxantrone—sarcoma	0.00302	0.00486	CcSEcCtD
Enoxaparin—Erythema—Mitoxantrone—sarcoma	0.00298	0.00479	CcSEcCtD
Enoxaparin—Hepatocellular injury—Doxorubicin—sarcoma	0.00294	0.00473	CcSEcCtD
Enoxaparin—Hyperkalaemia—Doxorubicin—sarcoma	0.00289	0.00465	CcSEcCtD
Enoxaparin—Ecchymosis—Epirubicin—sarcoma	0.00287	0.00462	CcSEcCtD
Enoxaparin—Confusional state—Thiotepa—sarcoma	0.00284	0.00457	CcSEcCtD
Enoxaparin—SERPINC1—Hemostasis—VEGFC—sarcoma	0.00284	0.0158	CbGpPWpGaD
Enoxaparin—Pulmonary oedema—Epirubicin—sarcoma	0.00283	0.00455	CcSEcCtD
Enoxaparin—Anaemia—Vincristine—sarcoma	0.00283	0.00455	CcSEcCtD
Enoxaparin—Skin exfoliation—Doxorubicin—sarcoma	0.00281	0.00451	CcSEcCtD
Enoxaparin—Oedema—Dactinomycin—sarcoma	0.00279	0.00449	CcSEcCtD
Enoxaparin—Thrombocytopenia—Thiotepa—sarcoma	0.00276	0.00443	CcSEcCtD
Enoxaparin—Anaemia—Mitoxantrone—sarcoma	0.00275	0.00443	CcSEcCtD
Enoxaparin—Thrombocytopenia—Dactinomycin—sarcoma	0.00273	0.0044	CcSEcCtD
Enoxaparin—Malaise—Mitoxantrone—sarcoma	0.00269	0.00432	CcSEcCtD
Enoxaparin—MPO—C-MYB transcription factor network—KIT—sarcoma	0.00266	0.0149	CbGpPWpGaD
Enoxaparin—Ecchymosis—Doxorubicin—sarcoma	0.00266	0.00428	CcSEcCtD
Enoxaparin—Diabetes mellitus—Epirubicin—sarcoma	0.00265	0.00427	CcSEcCtD
Enoxaparin—Pulmonary oedema—Doxorubicin—sarcoma	0.00262	0.00421	CcSEcCtD
Enoxaparin—Vascular purpura—Epirubicin—sarcoma	0.00258	0.00415	CcSEcCtD
Enoxaparin—Alopecia—Etoposide—sarcoma	0.00251	0.00405	CcSEcCtD
Enoxaparin—Anaphylactic shock—Vincristine—sarcoma	0.0025	0.00402	CcSEcCtD
Enoxaparin—Oedema—Vincristine—sarcoma	0.0025	0.00402	CcSEcCtD
Enoxaparin—Diabetes mellitus—Doxorubicin—sarcoma	0.00245	0.00395	CcSEcCtD
Enoxaparin—Confusional state—Mitoxantrone—sarcoma	0.00245	0.00394	CcSEcCtD
Enoxaparin—Thrombocytopenia—Vincristine—sarcoma	0.00244	0.00393	CcSEcCtD
Enoxaparin—Oedema—Mitoxantrone—sarcoma	0.00243	0.00391	CcSEcCtD
Enoxaparin—Anaphylactic shock—Mitoxantrone—sarcoma	0.00243	0.00391	CcSEcCtD
Enoxaparin—Dermatitis bullous—Epirubicin—sarcoma	0.00241	0.00388	CcSEcCtD
Enoxaparin—Pain—Thiotepa—sarcoma	0.00241	0.00387	CcSEcCtD
Enoxaparin—Purpura—Epirubicin—sarcoma	0.00239	0.00385	CcSEcCtD
Enoxaparin—Shock—Mitoxantrone—sarcoma	0.00239	0.00385	CcSEcCtD
Enoxaparin—Pain—Dactinomycin—sarcoma	0.00239	0.00384	CcSEcCtD
Enoxaparin—Vascular purpura—Doxorubicin—sarcoma	0.00238	0.00384	CcSEcCtD
Enoxaparin—Anaphylactoid reaction—Epirubicin—sarcoma	0.00238	0.00383	CcSEcCtD
Enoxaparin—Thrombocytopenia—Mitoxantrone—sarcoma	0.00238	0.00383	CcSEcCtD
Enoxaparin—Cardiac failure—Epirubicin—sarcoma	0.00236	0.0038	CcSEcCtD
Enoxaparin—Feeling abnormal—Thiotepa—sarcoma	0.00232	0.00373	CcSEcCtD
Enoxaparin—Feeling abnormal—Dactinomycin—sarcoma	0.0023	0.0037	CcSEcCtD
Enoxaparin—Anaemia—Etoposide—sarcoma	0.00229	0.00368	CcSEcCtD
Enoxaparin—MPO—Folate Metabolism—IL2—sarcoma	0.00227	0.0127	CbGpPWpGaD
Enoxaparin—Urticaria—Thiotepa—sarcoma	0.00224	0.0036	CcSEcCtD
Enoxaparin—Malaise—Etoposide—sarcoma	0.00223	0.00359	CcSEcCtD
Enoxaparin—Dermatitis bullous—Doxorubicin—sarcoma	0.00223	0.00359	CcSEcCtD
Enoxaparin—SERPINC1—Hemostasis—PLCG1—sarcoma	0.00223	0.0125	CbGpPWpGaD
Enoxaparin—Body temperature increased—Thiotepa—sarcoma	0.00222	0.00358	CcSEcCtD
Enoxaparin—Purpura—Doxorubicin—sarcoma	0.00221	0.00356	CcSEcCtD
Enoxaparin—Body temperature increased—Dactinomycin—sarcoma	0.00221	0.00355	CcSEcCtD
Enoxaparin—Anaphylactoid reaction—Doxorubicin—sarcoma	0.0022	0.00355	CcSEcCtD
Enoxaparin—Cardiac failure—Doxorubicin—sarcoma	0.00219	0.00352	CcSEcCtD
Enoxaparin—F10—Hemostasis—TEK—sarcoma	0.00218	0.0122	CbGpPWpGaD
Enoxaparin—Dyspnoea—Mitoxantrone—sarcoma	0.00217	0.00349	CcSEcCtD
Enoxaparin—Pain—Vincristine—sarcoma	0.00213	0.00343	CcSEcCtD
Enoxaparin—Pain—Mitoxantrone—sarcoma	0.00208	0.00334	CcSEcCtD
Enoxaparin—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.00208	0.00334	CcSEcCtD
Enoxaparin—Hypersensitivity—Thiotepa—sarcoma	0.00207	0.00334	CcSEcCtD
Enoxaparin—Hypersensitivity—Dactinomycin—sarcoma	0.00206	0.00331	CcSEcCtD
Enoxaparin—Confusional state—Etoposide—sarcoma	0.00204	0.00328	CcSEcCtD
Enoxaparin—Alanine aminotransferase increased—Epirubicin—sarcoma	0.00203	0.00327	CcSEcCtD
Enoxaparin—Anaphylactic shock—Etoposide—sarcoma	0.00202	0.00325	CcSEcCtD
Enoxaparin—Feeling abnormal—Mitoxantrone—sarcoma	0.002	0.00322	CcSEcCtD
Enoxaparin—F10—Hemostasis—ANGPT2—sarcoma	0.002	0.0112	CbGpPWpGaD
Enoxaparin—Pruritus—Thiotepa—sarcoma	0.00199	0.0032	CcSEcCtD
Enoxaparin—Thrombocytopenia—Etoposide—sarcoma	0.00198	0.00318	CcSEcCtD
Enoxaparin—Eosinophilia—Epirubicin—sarcoma	0.00197	0.00317	CcSEcCtD
Enoxaparin—Body temperature increased—Vincristine—sarcoma	0.00197	0.00317	CcSEcCtD
Enoxaparin—Urticaria—Mitoxantrone—sarcoma	0.00193	0.00311	CcSEcCtD
Enoxaparin—Diarrhoea—Thiotepa—sarcoma	0.00193	0.0031	CcSEcCtD
Enoxaparin—Body temperature increased—Mitoxantrone—sarcoma	0.00192	0.00309	CcSEcCtD
Enoxaparin—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.00192	0.00309	CcSEcCtD
Enoxaparin—Diarrhoea—Dactinomycin—sarcoma	0.00191	0.00308	CcSEcCtD
Enoxaparin—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.00188	0.00303	CcSEcCtD
Enoxaparin—Hypersensitivity—Vincristine—sarcoma	0.00184	0.00296	CcSEcCtD
Enoxaparin—MPO—C-MYB transcription factor network—CCND1—sarcoma	0.00183	0.0102	CbGpPWpGaD
Enoxaparin—Eosinophilia—Doxorubicin—sarcoma	0.00183	0.00294	CcSEcCtD
Enoxaparin—Dyspnoea—Etoposide—sarcoma	0.0018	0.0029	CcSEcCtD
Enoxaparin—Hypersensitivity—Mitoxantrone—sarcoma	0.00179	0.00288	CcSEcCtD
Enoxaparin—Pneumonia—Epirubicin—sarcoma	0.00179	0.00288	CcSEcCtD
Enoxaparin—Headache—Thiotepa—sarcoma	0.00176	0.00284	CcSEcCtD
Enoxaparin—Pain—Etoposide—sarcoma	0.00173	0.00278	CcSEcCtD
Enoxaparin—Diarrhoea—Vincristine—sarcoma	0.00171	0.00275	CcSEcCtD
Enoxaparin—Haematuria—Epirubicin—sarcoma	0.00169	0.00273	CcSEcCtD
Enoxaparin—Nausea—Thiotepa—sarcoma	0.00167	0.00269	CcSEcCtD
Enoxaparin—Feeling abnormal—Etoposide—sarcoma	0.00167	0.00268	CcSEcCtD
Enoxaparin—Diarrhoea—Mitoxantrone—sarcoma	0.00166	0.00268	CcSEcCtD
Enoxaparin—Nausea—Dactinomycin—sarcoma	0.00166	0.00267	CcSEcCtD
Enoxaparin—Pneumonia—Doxorubicin—sarcoma	0.00165	0.00266	CcSEcCtD
Enoxaparin—Urticaria—Etoposide—sarcoma	0.00161	0.00258	CcSEcCtD
Enoxaparin—Haemoglobin—Epirubicin—sarcoma	0.0016	0.00258	CcSEcCtD
Enoxaparin—F10—Hemostasis—VEGFC—sarcoma	0.0016	0.00896	CbGpPWpGaD
Enoxaparin—Body temperature increased—Etoposide—sarcoma	0.0016	0.00257	CcSEcCtD
Enoxaparin—Haemorrhage—Epirubicin—sarcoma	0.0016	0.00257	CcSEcCtD
Enoxaparin—MPO—C-MYB transcription factor network—NRAS—sarcoma	0.00157	0.00879	CbGpPWpGaD
Enoxaparin—Oedema peripheral—Epirubicin—sarcoma	0.00157	0.00253	CcSEcCtD
Enoxaparin—Haematuria—Doxorubicin—sarcoma	0.00157	0.00252	CcSEcCtD
Enoxaparin—Headache—Vincristine—sarcoma	0.00156	0.00252	CcSEcCtD
Enoxaparin—Headache—Mitoxantrone—sarcoma	0.00152	0.00245	CcSEcCtD
Enoxaparin—Hypersensitivity—Etoposide—sarcoma	0.00149	0.0024	CcSEcCtD
Enoxaparin—Haemoglobin—Doxorubicin—sarcoma	0.00148	0.00239	CcSEcCtD
Enoxaparin—Nausea—Vincristine—sarcoma	0.00148	0.00239	CcSEcCtD
Enoxaparin—Haemorrhage—Doxorubicin—sarcoma	0.00148	0.00237	CcSEcCtD
Enoxaparin—MPO—C-MYB transcription factor network—MYC—sarcoma	0.00147	0.00819	CbGpPWpGaD
Enoxaparin—MPO—Folate Metabolism—TP53—sarcoma	0.00146	0.00815	CbGpPWpGaD
Enoxaparin—Oedema peripheral—Doxorubicin—sarcoma	0.00145	0.00234	CcSEcCtD
Enoxaparin—Nausea—Mitoxantrone—sarcoma	0.00144	0.00232	CcSEcCtD
Enoxaparin—Pruritus—Etoposide—sarcoma	0.00143	0.0023	CcSEcCtD
Enoxaparin—Alopecia—Epirubicin—sarcoma	0.00141	0.00227	CcSEcCtD
Enoxaparin—Erythema—Epirubicin—sarcoma	0.00139	0.00223	CcSEcCtD
Enoxaparin—Diarrhoea—Etoposide—sarcoma	0.00138	0.00223	CcSEcCtD
Enoxaparin—MPO—C-MYB transcription factor network—KRAS—sarcoma	0.00135	0.00756	CbGpPWpGaD
Enoxaparin—Alopecia—Doxorubicin—sarcoma	0.0013	0.0021	CcSEcCtD
Enoxaparin—Erythema—Doxorubicin—sarcoma	0.00128	0.00207	CcSEcCtD
Enoxaparin—Anaemia—Epirubicin—sarcoma	0.00128	0.00206	CcSEcCtD
Enoxaparin—Headache—Etoposide—sarcoma	0.00127	0.00204	CcSEcCtD
Enoxaparin—F10—Hemostasis—PLCG1—sarcoma	0.00126	0.00704	CbGpPWpGaD
Enoxaparin—Malaise—Epirubicin—sarcoma	0.00125	0.00201	CcSEcCtD
Enoxaparin—Nausea—Etoposide—sarcoma	0.0012	0.00193	CcSEcCtD
Enoxaparin—Anaemia—Doxorubicin—sarcoma	0.00119	0.00191	CcSEcCtD
Enoxaparin—Malaise—Doxorubicin—sarcoma	0.00116	0.00186	CcSEcCtD
Enoxaparin—MPO—C-MYB transcription factor network—HRAS—sarcoma	0.00115	0.00643	CbGpPWpGaD
Enoxaparin—Confusional state—Epirubicin—sarcoma	0.00114	0.00184	CcSEcCtD
Enoxaparin—Oedema—Epirubicin—sarcoma	0.00113	0.00182	CcSEcCtD
Enoxaparin—Anaphylactic shock—Epirubicin—sarcoma	0.00113	0.00182	CcSEcCtD
Enoxaparin—Shock—Epirubicin—sarcoma	0.00111	0.00179	CcSEcCtD
Enoxaparin—Thrombocytopenia—Epirubicin—sarcoma	0.00111	0.00179	CcSEcCtD
Enoxaparin—Confusional state—Doxorubicin—sarcoma	0.00106	0.0017	CcSEcCtD
Enoxaparin—Oedema—Doxorubicin—sarcoma	0.00105	0.00169	CcSEcCtD
Enoxaparin—Anaphylactic shock—Doxorubicin—sarcoma	0.00105	0.00169	CcSEcCtD
Enoxaparin—Shock—Doxorubicin—sarcoma	0.00103	0.00166	CcSEcCtD
Enoxaparin—Thrombocytopenia—Doxorubicin—sarcoma	0.00103	0.00165	CcSEcCtD
Enoxaparin—Dyspnoea—Epirubicin—sarcoma	0.00101	0.00163	CcSEcCtD
Enoxaparin—Pain—Epirubicin—sarcoma	0.000969	0.00156	CcSEcCtD
Enoxaparin—Dyspnoea—Doxorubicin—sarcoma	0.000935	0.0015	CcSEcCtD
Enoxaparin—Feeling abnormal—Epirubicin—sarcoma	0.000934	0.0015	CcSEcCtD
Enoxaparin—Urticaria—Epirubicin—sarcoma	0.0009	0.00145	CcSEcCtD
Enoxaparin—Pain—Doxorubicin—sarcoma	0.000897	0.00144	CcSEcCtD
Enoxaparin—Body temperature increased—Epirubicin—sarcoma	0.000896	0.00144	CcSEcCtD
Enoxaparin—Feeling abnormal—Doxorubicin—sarcoma	0.000864	0.00139	CcSEcCtD
Enoxaparin—SERPINC1—Hemostasis—IL2—sarcoma	0.000848	0.00474	CbGpPWpGaD
Enoxaparin—Hypersensitivity—Epirubicin—sarcoma	0.000835	0.00134	CcSEcCtD
Enoxaparin—Urticaria—Doxorubicin—sarcoma	0.000833	0.00134	CcSEcCtD
Enoxaparin—Body temperature increased—Doxorubicin—sarcoma	0.000829	0.00133	CcSEcCtD
Enoxaparin—Pruritus—Epirubicin—sarcoma	0.000802	0.00129	CcSEcCtD
Enoxaparin—Diarrhoea—Epirubicin—sarcoma	0.000775	0.00125	CcSEcCtD
Enoxaparin—Hypersensitivity—Doxorubicin—sarcoma	0.000773	0.00124	CcSEcCtD
Enoxaparin—Pruritus—Doxorubicin—sarcoma	0.000742	0.00119	CcSEcCtD
Enoxaparin—SERPINC1—Hemostasis—SRC—sarcoma	0.00074	0.00413	CbGpPWpGaD
Enoxaparin—SERPINC1—Hemostasis—VEGFA—sarcoma	0.000721	0.00403	CbGpPWpGaD
Enoxaparin—Diarrhoea—Doxorubicin—sarcoma	0.000717	0.00115	CcSEcCtD
Enoxaparin—SERPINC1—Hemostasis—NRAS—sarcoma	0.000712	0.00398	CbGpPWpGaD
Enoxaparin—Headache—Epirubicin—sarcoma	0.00071	0.00114	CcSEcCtD
Enoxaparin—Nausea—Epirubicin—sarcoma	0.000673	0.00108	CcSEcCtD
Enoxaparin—Headache—Doxorubicin—sarcoma	0.000657	0.00106	CcSEcCtD
Enoxaparin—Nausea—Doxorubicin—sarcoma	0.000623	0.001	CcSEcCtD
Enoxaparin—SERPINC1—Hemostasis—KRAS—sarcoma	0.000613	0.00342	CbGpPWpGaD
Enoxaparin—SERPINC1—Hemostasis—TP53—sarcoma	0.000545	0.00304	CbGpPWpGaD
Enoxaparin—SERPINC1—Hemostasis—HRAS—sarcoma	0.000521	0.00291	CbGpPWpGaD
Enoxaparin—F10—Hemostasis—IL2—sarcoma	0.000479	0.00268	CbGpPWpGaD
Enoxaparin—F10—Metabolism of proteins—MMP2—sarcoma	0.000475	0.00265	CbGpPWpGaD
Enoxaparin—F10—Hemostasis—SRC—sarcoma	0.000418	0.00234	CbGpPWpGaD
Enoxaparin—F10—Hemostasis—VEGFA—sarcoma	0.000407	0.00228	CbGpPWpGaD
Enoxaparin—F10—Hemostasis—NRAS—sarcoma	0.000402	0.00225	CbGpPWpGaD
Enoxaparin—F10—Metabolism of proteins—CTNNB1—sarcoma	0.000364	0.00203	CbGpPWpGaD
Enoxaparin—F10—Hemostasis—KRAS—sarcoma	0.000346	0.00193	CbGpPWpGaD
Enoxaparin—F10—Hemostasis—TP53—sarcoma	0.000308	0.00172	CbGpPWpGaD
Enoxaparin—F10—Hemostasis—HRAS—sarcoma	0.000294	0.00164	CbGpPWpGaD
